Trials / Completed
CompletedNCT03807492
Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 241 (actual)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The EMPOWeR study is proposed as a cohort study with longitudinal follow-up to determine rates of genetic mutations among men with or at-risk for prostate cancer to address the various facets of genetic education and counseling for optimized genetic assessment and wellness of men. The results will inform practice guidelines and future studies for maximal impact of genetic evaluation of men for inherited prostate cancer.
Conditions
Timeline
- Start date
- 2019-01-16
- Primary completion
- 2022-06-01
- Completion
- 2024-02-07
- First posted
- 2019-01-17
- Last updated
- 2025-05-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03807492. Inclusion in this directory is not an endorsement.